) Why is relapse far and away the most likely outcome of a cessation attempt? It is difficult to imagine answers to this question that do not implicate tobacco dependence. Dependence is the conceptual nexus integrating the surface features of addiction (e.g., heavy use, severe withdrawal, tendency to relapse, etc.). Greater understanding of the construct linking those phenomena should foster more rapid progress in developing effective treatments. The overarching goal of this research is to develop improved dependence- assessment instruments through theoretical scale construction that focuses on hypothesized mechanisms underlying dependence, rather than on surface manifestations (e.g., cigarettes per day, whether one inhales). Once initial scales are constructed, they will be subjected to diverse validity assessments. Two studies are proposed. In Study I, 460 smokers will be recruited such that they reflect a broad range of dependence. All will participate in a cessation trial with random assignment to 2 or 4 mg nicotine gum or placebo. Three theory-based constructs will serve as chief criteria for the selection of Subscale on the Dependence Questionnaire (DQ): withdrawal severity, pre-cessation smoking heaviness, and relapse. These will be assessed with multiple, sensitive indices. For example, assessments of withdrawal will include measures of both symptom elevation and symptom trajectory. Moreover, over the first five days of cessation, intensive assessment of symptoms will occur via computerized telephone interview. Two additional measures will be gathered because of their strong motivational links to dependence. Genetic markers related to dopaminergic structures and activities will be assessed in all 460 subjects. In addition, a subsample of placebo subjects (N=60) will participate in a behavioral economic assessment, allowing examination of elasticity as a dependence index and providing a further criterion against which to test the DQ. Study 2 (N=400) will employ the same design with two exceptions. First, the study will not involve the elasticity assessment. Second, the active smoking cessation pharmacotherapy will be changed to bupropion so that the stability of the factor structure and predictive validity of the DQ can be determined in a systematic replication. The validity data will address both vital clinical as well as theoretically significant criteria.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA084724-02
Application #
6356243
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2000-09-25
Project End
2001-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
$595,693
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Glasheen, Cristie; Johnson, Eric O; Saccone, Nancy L et al. (2018) Is the Fagerström test for nicotine dependence invariant across secular trends in smoking? A question for cross-birth cohort analysis of nicotine dependence. Drug Alcohol Depend 185:127-132
Teitelbaum, A M; Murphy, S E; Akk, G et al. (2018) Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain. Pharmacogenomics J 18:136-143
Singh, Tarjinder; Walters, James T R; Johnstone, Mandy et al. (2017) The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet 49:1167-1173
Peckham-Gregory, Erin C; Chakraborty, Rikhia; Scheurer, Michael E et al. (2017) A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility. Blood 130:2229-2232
Taylor, Kimberly E; Wong, Quenna; Levine, David M et al. (2017) Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry. Arthritis Rheumatol 69:1294-1305
Mercati, O; Huguet, G; Danckaert, A et al. (2017) CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders. Mol Psychiatry 22:625-633
Chen, Li-Shiun; Baker, Timothy; Brownson, Ross C et al. (2017) Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives. Community Ment Health J 53:695-702
Johnson, Eric O; Hancock, Dana B; Levy, Joshua L et al. (2016) KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. Addict Biol 21:1217-1232
Rees, Elliott; Kendall, Kimberley; Pardiñas, Antonio F et al. (2016) Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia. JAMA Psychiatry 73:963-969

Showing the most recent 10 out of 86 publications